Please be advised, the Wilmington Office of the Delaware Department of Insurance has moved to a new location effective June 30th, 2023. The new address for the Wilmington office is: 503 Carr Road, Suite 303, Wilmington, Delaware 19809. (All payments should be mailed to 1351 West North Street, Suite 101, Dover, Delaware 19904.)
Medicaid Unwinding FAQ – See More Info
COVID-19 Insurance FAQ - See More Info
In recent years, Delaware has acted to improve healthcare quality and bend the healthcare cost growth curve by:
To further help bend the healthcare cost growth curve, in 2019, Senate Bill 116 of the 150th Delaware General Assembly directed the DOI to create the Office of Value Based Health Care Delivery to “reduce health-care costs by increasing the availability of high quality, cost-efficient health insurance products with stable, predictable, and affordable rates.” SB 116 charged the Office with three tasks:
By October 2021, Delaware’s Legislature passed Senate Substitute 1 for Senate Bill 120 and Governor Carney signed it into law. This legislation recognizes the benefits of effective primary care and aims to make it more accessible to all Delawareans. It is based on findings and Affordability Standards outlined in the Office’s inaugural report below. In 2021 the Office updated its report and published an Annual Review of Carrier Progress Towards Meeting Affordability Standards to provide a baseline with which to measure future progress. The report reinforces the need for the new law, and highlights opportunities for meaningful progress that will improve the physical, mental, and financial health of Delawareans.
Following this series of recent statutory and regulatory changes, the Office published the 2023 Annual Report which outlines carriers’ projected compliance with requirements for 2023 in the first year of implementation.
Effective May 11, 2022, the Department will implement SS1 for SB120 through Regulation 1322 Requirements for Mandatory Minimum Payment Innovations in Health Insurance.
The proposed regulation was published in the January 1, 2022 edition of the Register of Regulations and the Final Implementation Order was published in the May 1, 2022 edition of the Register of Regulations.
(see also the Department’s Proposed/Adopted Regulations & General Notices webpage for access to the regulation).
Spending on prescription drugs increased a cumulative 77% nationally from 2010 to 2020 . Prescription Drug Spending and Rebates in Delaware, prepared by the DOI Office of Value-Based Health Care Delivery, provides a baseline understanding of pharmaceutical spending in the state and will inform state policymakers, regulators, health care purchasers, and consumer advocates as they consider future efforts to improve consumers’ access to affordable prescription drugs while addressing unsustainable increases in their cost.
To further improve affordability and access to high value, evidence-based care, the Office was awarded a Center for Consumer Information and Insurance Oversight (CCIIO) Cycle II Grant. One component of the project is to evaluate three of the most commonly purchased individual and small group plan offerings in the Marketplace to monitor compliance with state and federal law. This Delaware EHB Health Plan Compliance Report provides an overview of these findings.
Additional reports prepared by the Office on primary care investment and health care affordability in Delaware can be found below:
“Investing in Primary Care: Lessons from State-Based Efforts” is a national scan of state actions to increase primary care investment. The report, published in April 2022, features Delaware as an emerging national leader in this important work. The scan was released as part of Primary Care Matters , a new resource center developed by California Health Care Foundation.
Related Topics: affordability standards, delaware department of insurance, Department of Insurance, insurance, Office of Value Based Health Care Delivery, OVBHCD, primary care investment, primary care spending, State of Delaware